MERS-CoV 抗体

Folegatti, Bittaye, Flaxman, Lopez, Bellamy, Kupke, Mair, Makinson, Sheridan, Rohde, Halwe, Jeong, Park, Kim, Song, Boyd, Tran, Silman, Poulton, Datoo, Marshal, Themistocleous, Lawrie, Roberts et al.: "Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. ..." in: The Lancet. Infectious diseases, (2020) (PubMed).

Langenmayer, Lülf-Averhoff, Adam-Neumair, Fux, Sutter, Volz: "Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S." in: Biologicals : journal of the International Association of Biological Standardization, Vol. 54, pp. 58-62, (2018) (PubMed).

Zhao, Zhou, Zhang, Chu, Liu, Poon, Chan, Leung, Fai, Lin, Zhang, Jin, Yuen, Zheng: "A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses." in: Scientific reports, Vol. 6, pp. 22008, (2016) (PubMed).

Hart, Dyall, Postnikova, Zhou, Kindrachuk, Johnson, Olinger, Frieman, Holbrook, Jahrling, Hensley: "Interferon-? and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays." in: The Journal of general virology, Vol. 95, Issue Pt 3, pp. 571-7, (2014) (PubMed).

Dyall, Coleman, Hart, Venkataraman, Holbrook, Kindrachuk, Johnson, Olinger, Jahrling, Laidlaw, Johansen, Lear-Rooney, Glass, Hensley, Frieman: "Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection." in: Antimicrobial agents and chemotherapy, Vol. 58, Issue 8, pp. 4885-93, (2014) (PubMed).